{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06241183",
            "orgStudyIdInfo": {
                "id": "IRB2023-00188"
            },
            "organization": {
                "fullName": "Stony Brook University",
                "class": "OTHER"
            },
            "briefTitle": "Famotidine and Antacids for Treatment of Dyspepsia",
            "officialTitle": "Comparing Intravenous Famotidine and Oral Antacids in the Treatment of Dyspepsia in the Emergency Department",
            "therapeuticArea": [
                "Other"
            ],
            "study": "famotidine-and-antacids-for-treatment-of-dyspepsia"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-11-09",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-01-16",
            "studyFirstSubmitQcDate": "2024-01-26",
            "studyFirstPostDateStruct": {
                "date": "2024-02-05",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-19",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-22",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Adam Singer",
                "investigatorTitle": "Professor and Interim Chair of the Department of Emergency Medicine",
                "investigatorAffiliation": "Stony Brook University"
            },
            "leadSponsor": {
                "name": "Stony Brook University",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "The aim of this study is to compare intravenous famotidine, an H2 receptor antagonist, and Maalox/ Mylanta, an oral antacid, in treatment of dyspepsia in the emergency department. The goal of this study is to reduce patients' pain based on the verbal numerical pain scale. The anticipated outcome is for pain levels in both groups to decrease. It is expected that antacids will improve symptoms more quickly and to a greater degree within an hour of taking medication based on the results of similar studies.",
            "detailedDescription": "This study will be conducted in the Emergency Department at Stony Brook University Hospital. Investigators intend to enroll approximately 80 patients who present to the emergency department with dyspepsia symptoms. The patients will be randomized to one of two groups: one group will receive 20 mg of intravenous famotidine and the other will receive 30 ml of oral Maalox/ Mylanta. The verbal numeric pain score (VNP) will be used to measure pain at 0 minutes, 15 minutes, 30 minutes, 45 minutes, and 60 minutes after administration of the study drug. Pain severity assessments will be performed by an investigator blinded to study treatment. Data will also be collected regarding demographic, clinical information, patient satisfaction and the need for rescue medications in each of the two study groups at the end of the 60-minute study period. At the end of the study period, the patients may be treated with additional analgesia at the discretion of their ED provider."
        },
        "conditionsModule": {
            "conditions": [
                "Dyspepsia",
                "GERD",
                "Acid Reflux"
            ],
            "keywords": [
                "dyspepsia",
                "GERD",
                "Acid Reflux",
                "H2 receptor antagonist",
                "antacid",
                "Maalox",
                "Mylanta",
                "Famotidine"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Subjects are divided into two groups and randomly assigned to receive either study drug.",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "maskingDescription": "The research team member assessing verbal pain score will be blinded to the treatment.",
                    "whoMasked": [
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 80,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Intravenous Famotidine",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Patients in this group will receive 20 mg of intravenous famotidine.",
                    "interventionNames": [
                        "Drug: Intravenous Famotidine"
                    ]
                },
                {
                    "label": "Oral Maalox",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Patients in the group will receive 30 ml of oral Maalox/ Mylanta.",
                    "interventionNames": [
                        "Drug: Oral Maalox/ Mylanta"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Intravenous Famotidine",
                    "description": "Patients in this group will receive 20mg IV Famotidine.",
                    "armGroupLabels": [
                        "Intravenous Famotidine"
                    ],
                    "otherNames": [
                        "H2 Receptor Antagonist"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Oral Maalox/ Mylanta",
                    "description": "Patients in this group will receive 30 ml Maalox/ Mylanta.",
                    "armGroupLabels": [
                        "Oral Maalox"
                    ],
                    "otherNames": [
                        "Antacid"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Verbal Numerical Pain Score",
                    "description": "Patients will be asked to rate their pain on a scale of 0 to 10 with 0 indicating no pain and 10 indicating the worst pain imaginable every 15 minutes for 60 minutes.",
                    "timeFrame": "at 1 hour"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Need for Rescue Medications",
                    "description": "Investigators will assess frequency of need for rescue medications between groups.",
                    "timeFrame": "at 1 hour"
                },
                {
                    "measure": "Satisfaction with Assigned Medication",
                    "description": "Investigators will gather data regarding patient satisfaction with their assigned treatment using a 5 item likert scale from very dissatisfied to very satisfied",
                    "timeFrame": "at 1 hour"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Subject Age \u2265 18 years of age\n2. Patient diagnosed with dyspepsia\n3. Present at the ED with upper abdominal pain score of at least 3\n\nExclusion Criteria:\n\n1. Hypersensitivity to an ingredient in Maalox/ Mylanta or Famotidine\n2. Moderate to Severe Renal Insufficiency (precaution)\n3. Kidney Failure\n4. Pregnant or Nursing\n5. Verbal pain score less than 3\n6. Inability to tolerate oral medications\n7. Bowel Obstruction\n8. Proton pump inhibitor within 2 hours of study treatment",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Adam Singer, MD",
                    "role": "CONTACT",
                    "phone": "6314447857",
                    "email": "adam.singer@stonybrookmedicine.edu"
                }
            ],
            "locations": [
                {
                    "facility": "Stony Brook University Hospital",
                    "status": "RECRUITING",
                    "city": "Stony Brook",
                    "state": "New York",
                    "zip": "11794",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Andrea Gowie",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Adam Singer, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.92565,
                        "lon": -73.14094
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000005764",
                    "term": "Gastroesophageal Reflux"
                },
                {
                    "id": "D000004415",
                    "term": "Dyspepsia"
                }
            ],
            "ancestors": [
                {
                    "id": "D000012817",
                    "term": "Signs and Symptoms, Digestive"
                },
                {
                    "id": "D000015154",
                    "term": "Esophageal Motility Disorders"
                },
                {
                    "id": "D000003680",
                    "term": "Deglutition Disorders"
                },
                {
                    "id": "D000004935",
                    "term": "Esophageal Diseases"
                },
                {
                    "id": "D000005767",
                    "term": "Gastrointestinal Diseases"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M8880",
                    "name": "Gastroesophageal Reflux",
                    "asFound": "Acid Reflux",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7796",
                    "name": "Emergencies",
                    "relevance": "LOW"
                },
                {
                    "id": "M7589",
                    "name": "Dyspepsia",
                    "asFound": "Dyspepsia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15622",
                    "name": "Signs and Symptoms, Digestive",
                    "relevance": "LOW"
                },
                {
                    "id": "M17874",
                    "name": "Esophageal Motility Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M17875",
                    "name": "Esophageal Spasm, Diffuse",
                    "relevance": "LOW"
                },
                {
                    "id": "M6882",
                    "name": "Deglutition Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M8085",
                    "name": "Esophageal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC09",
                    "name": "Ear, Nose, and Throat Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000015738",
                    "term": "Famotidine"
                },
                {
                    "id": "D000000863",
                    "term": "Antacids"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000897",
                    "term": "Anti-Ulcer Agents"
                },
                {
                    "id": "D000005765",
                    "term": "Gastrointestinal Agents"
                },
                {
                    "id": "D000006635",
                    "term": "Histamine H2 Antagonists"
                },
                {
                    "id": "D000006633",
                    "term": "Histamine Antagonists"
                },
                {
                    "id": "D000018494",
                    "term": "Histamine Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M251057",
                    "name": "TEMPO",
                    "relevance": "LOW"
                },
                {
                    "id": "M18303",
                    "name": "Famotidine",
                    "asFound": "Taxotere",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4188",
                    "name": "Antacids",
                    "asFound": "Stabilize",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9711",
                    "name": "Histamine H2 Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M186190",
                    "name": "Aluminum hydroxide, magnesium hydroxide, simethicone drug combination",
                    "relevance": "LOW"
                },
                {
                    "id": "M4219",
                    "name": "Anti-Ulcer Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M186193",
                    "name": "Aluminum hydroxide, magnesium hydroxide, drug combination",
                    "relevance": "LOW"
                },
                {
                    "id": "M8881",
                    "name": "Gastrointestinal Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M9708",
                    "name": "Histamine",
                    "relevance": "LOW"
                },
                {
                    "id": "M212144",
                    "name": "Histamine phosphate",
                    "relevance": "LOW"
                },
                {
                    "id": "M9709",
                    "name": "Histamine Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                }
            ]
        }
    },
    "hasResults": false
}